Advanced Grafting Biomaterials and Technologies in Chronic Wound Care: Mechanisms, Clinical Outcomes, and Therapeutic Integration
Source abstract
Abstract
Chronic wounds remain a major clinical and economic burden due to persistent inflammation, impaired perfusion, microbial biofilms, and dysregulated immune responses that collectively stall epithelialization. Polymicrobial bacterial–fungal biofilms, including Candida species, further delay healing by sustaining inflammation and promoting treatment-resistant infection. Recent advances have accelerated the development of bioengineered skin substitutes, collagen matrices, and placental-derived grafts that modulate macrophage polarization, reactive oxygen species signaling, and extracellular matrix remodeling to restore tissue architecture and promote neovascularization. Their effectiveness, however, depends on integration within structured care pathways that emphasize debridement, moisture balance, and infection control. Artificial intelligence, three-dimensional bioprinting, flexible microelectronic sensors for real-time wound monitoring, and bioactive compounds derived from traditional Chinese medicine, are expanding the therapeutic landscape. Together, these innovations support a shift toward predictive, personalized, and regenerative wound-care strategies. This review aims to provide a mechanistic and clinically contextualized overview of advanced grafting biomaterials, highlighting current applications, limitations, and future directions in chronic wound care.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Wound Healing and Treatments · Planarian Biology and Electrostimulation · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Innovative Wound Care (IWC), Fresno, CA 93710, USA
Department of Chemistry, Bar-Ilan University, Ramat-Gan 52900, Israel
Bar-Ilan Institute for Nanotechnology and Advanced Material, Bar-Ilan University, Ramat-Gan 52900, Israel
School of Chemistry, University College Cork, T12 YN60 Cork, Ireland
References (100+)
Show source-provided references
1. Global burden of diabetic foot ulcers: A systematic review on prevalence, mortality, and clinical-economic impact10.33448/rsd-v14i7.49222 ↗
2. A narrative review of the epidemiology and economics of chronic wounds10.1111/bjd.20692 ↗
3. The economic burden of chronic wounds on global healthcare systems10.2478/picbe-2025-0155 ↗
4. Jin, C., Jin, Y., Ding, Z., Nuch, K.S., Han, M., Shim, J., Chien, P.N., and Heo, C.Y. (2025). Cellular and molecular mechanisms of wound repair: From biology to therapeutic innovation. Cells, 14.10.3390/cells14231850 ↗
5. Krzyszczyk, P., Schloss, R., Palmer, A., and Berthiaume, F. (2018). The role of macrophages in acute and chronic wound healing and interventions to promote pro-wound healing phenotypes. Front. Physiol., 9.10.3389/fphys.2018.00419 ↗
6. Therapeutic properties of M2 macrophages in chronic wounds: An innovative area of biomaterial-assisted M2 macrophage targeted therapy10.1007/s12015-024-10806-3 ↗
7. Clinical approach to wounds: Débridement and wound bed preparation including the use of dressings and wound-healing adjuvants10.1097/01.prs.0000225470.42514.8f ↗
8. Once daily bromelain-based enzymatic debridement of venous leg ulcers versus gel vehicle (placebo) and non-surgical standard of care: A three-arm multicenter, double-blinded, randomized controlled study10.1016/j.eclinm.2024.102750 ↗
9. Challenges in the treatment of chronic wounds10.1089/wound.2015.0635 ↗
10. A comprehensive overview of chronic wound infections and current treatment methods10.1111/wrr.70115 ↗
11. Management of acute wounds-expert panel consensus statement10.1089/wound.2023.0059 ↗
12. Haxho, F., Lytvyn, Y., Shelley, A.J., Ortega, A., Melin, M., and Alavi, A. (J. Am. Acad. Dermatol., 2025). Wound care—Part I: A practical approach to local wound care and dressing selection, J. Am. Acad. Dermatol., in press.10.1016/j.jaad.2025.02.103 ↗
13. concept for the local therapy of chronic wounds: An international update10.1177/15347346241245159 ↗
14. Management of diabetic foot ulcers on adjunctive therapy: A systematic review
15. Negative pressure wound therapy: Past, present and future10.1111/iwj.12170 ↗
16. Use of subatmospheric pressure therapy to prevent burn wound progression in humans: First experiences10.1016/j.burns.2003.12.003 ↗
17. Negative pressure wound therapy combined with instillation for sternoclavicular joint infection10.1016/j.athoracsur.2020.04.037 ↗
18. Advanced therapies in wound management: Cell and tissue-based therapies, physical and biophysical therapies, smart and IT-based technologies10.12968/jowc.2018.27.Sup6a.S1 ↗
19. WHS guidelines for the treatment of pressure ulcers—2023 update10.1111/wrr.13130 ↗
20. Regenerative medicine approaches for skin wound healing: From allografts to engineered skin substitutes10.1007/s40472-024-00453-5 ↗
21. On skin substitutes for wound healing: Current products, limitations, and future perspectives10.1142/S2339547820300024 ↗
22. Skin grafting for dermatologists: Past, present, and future10.1007/s13671-024-00427-x ↗
23. Skin substitutes for acute and chronic wound healing: An updated review10.1080/09546634.2018.1530443 ↗
24. A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers10.1111/iwj.12395 ↗
25. Effect of silver on burn wound infection control and healing: Review of the literature10.1016/j.burns.2006.06.010 ↗
26. Wound healing and its impairment in the diabetic foot10.1016/S0140-6736(05)67700-8 ↗
27. Kharade, P.P. (2024). Application of various tissue grafts. Prosthetic Rehabilitation of Head and Neck Cancer Patients, Elsevier.10.1016/B978-0-323-82394-4.00004-5 ↗
28. Dean, J., Hoch, C., Wollenberg, B., Navidzadeh, J., Maheta, B., Mandava, A., Knoedler, S., Sherwani, K., Baecher, H., and Schmitz, A. (2025). Advancements in bioengineered and autologous skin grafting techniques for skin reconstruction: A comprehensive review. Front. Bioeng. Biotechnol., 12.10.3389/fbioe.2024.1461328 ↗
29. Advancement of wound care from grafts to bioengineered smart skin substitutes10.1007/s40204-014-0030-y ↗
30. Narrative review on efficacy of cell- and tissue-based therapies for diabetic foot ulcer10.1002/adtp.202400335 ↗
31. Skin substitutes to enhance wound healing
32. In situ tissue engineering with Integra—A new paradigm of surgical wound repair10.1111/j.1067-1927.2005.130216ae.x ↗
33. The role of dermal matrices in treating inflammatory and diabetic wounds10.1097/PRS.0000000000002652 ↗
34. Managing venous leg ulcers with fetal bovine acellular dermal matrix: A single centre retrospective study10.12968/jowc.2017.26.Sup10.S12 ↗
35. Organogenesis, Inc (2026, March 17). Apligraf®: Product Information and Clinical Use. Available online: https://www.apligraf.com/.
36. Organogenesis, Inc (2026, March 17). Dermagraft®: Advanced Wound Care Patient Brochure. Available online: https://www.organogenesis.com/pdf/advanced-wound-care-dermagraft-patient-brochure.pdf.
37. Integra LifeSciences (2026, March 17). Integra® Dermal Regeneration Template: Product Information. Available online: https://products.integralife.com/integra-dermal-regeneration-template/product/wound-reconstruction-care-inpatient-acute-or-integra-dermal-regeneration-template.
38. Integra LifeSciences (2026, March 17). PriMatrix® Dermal Repair Scaffold: Product Information. Available online: https://products.integralife.com/primatrix-dermal-scaffold/product/wound-reconstruction-care-outpatient-clinic-private-office-treat-primatrix-dermal-repair-scaffold.
39. The efficacy and safety of Grafix® for the treatment of chronic diabetic foot ulcers: Results of a multi-centre, controlled, randomised, blinded, clinical trial10.1111/iwj.12329 ↗
40. (2026, March 17). Integra LifeSciences Launches AmnioExcel Plus Placental Allograft Membrane. FirstWorld HEALTHTECH. Available online: https://firstwordhealthtech.com/story/4958407.
41. Mitchell, K. (2025). Clinical experience using a dual-layer amniotic membrane allograft on a posterior upper-thigh pressure ulcer. Reports, 8.10.3390/reports8040199 ↗
42. Experience with a synthetic bilayer biodegradable temporising matrix in significant burn injury10.1016/j.burnso.2017.08.001 ↗
43. Role of synthetic dermal matrix for reconstruction of complex non-graftable wound defects10.1093/jbcr/irac012.278 ↗
44. Use of a synthetic dermal matrix for reconstruction of 55 patients with nongraftable wounds and management of complications10.1093/jbcr/irad012 ↗
45. Clinical applications of acellular dermal matrices: A review10.1177/20595131211038313 ↗
46. Extracellular matrix structure and function10.1016/j.addr.2015.11.001 ↗
47. Collagen-based biomaterials for wound healing10.1002/bip.22486 ↗
48. Growth factors and cytokines in wound healing10.1111/j.1524-475X.2008.00410.x ↗
49. Inflammation and metabolism in tissue repair and regeneration10.1126/science.aam7928 ↗
50. Properties of dehydrated human amnion/chorion composite grafts: Implications for wound repair and soft tissue regeneration10.1002/jbm.b.33141 ↗
51. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers10.1046/j.1524-475X.2002.10903.x ↗
52. Angiogenesis in wound healing10.1046/j.1087-0024.2000.00014.x ↗
53. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells10.1016/S0002-9440(10)63754-6 ↗
54. Antimicrobial peptides and wound healing: Biological and therapeutic considerations10.1111/exd.12929 ↗
55. Antibacterial properties of human amnion and chorion in vitro10.1016/S0301-2115(00)00345-6 ↗
56. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update)10.1002/dmrr.3280 ↗
57. Venous leg ulcers—The search for a prognostic indicator10.1111/j.1742-481X.2007.00335.x ↗
58. Biofilms in chronic wounds10.1111/j.1524-475X.2007.00321.x ↗
59. Burn wound infections10.1128/CMR.19.2.403-434.2006 ↗
60. Biofilm exacerbates antibiotic resistance: Is this a current oversight in antimicrobial stewardship?10.1186/s13756-020-00830-6 ↗
61. Cost-effectiveness of wound care: A concept analysis
62. Cost-effectiveness of negative pressure wound therapy in patients with many comorbidities and severe wounds of various etiology10.1111/wrr.12483 ↗
63. Clinical and cost efficacy of advanced wound care matrices in the treatment of venous leg ulcers: A systematic review10.12968/jowc.2021.30.7.553 ↗
64. Negative pressure wound therapy for surgical wounds healing by secondary intention is not cost-effective10.1093/bjs/znaf077 ↗
65. Single-use negative pressure wound therapy reduces costs in closed surgical incisions: UK and US economic evaluation10.12968/jowc.2021.30.Sup5.S23 ↗
66. What’s new in wound treatment: A critical appraisal10.1002/dmrr.2747 ↗
67. An update and review of cell-based wound dressings and their integration into clinical practice10.21037/atm.2016.12.44 ↗
68. Attinger, C.E., and Steinberg, J.S. (2023). Science and practicality of tissue products in limb salvage. Functional Limb Salvage. The Multidisciplinary Team Approach, Springer. Available online: https://link.springer.com/content/pdf/10.1007/978-3-031-27725-2.pdf.
69. Allogeneic skin substitutes versus human placental membrane products in the management of diabetic foot ulcers: A narrative comparative evaluation of the literature10.1177/1534734618818301 ↗
70. Harmon, K.A., Kimmerling, K.A., Avery, J.T., and Mowry, K.C. (2024). Hypothermically stored amnion is robust and provides a scaffold for supporting wound healing by retaining the characteristics of native tissue. Int. J. Mol. Sci., 25.10.3390/ijms251910347 ↗
71. Advanced therapies for chronic wounds: NPWT, engineered skin, growth factors, extracellular matrices10.1111/dth.12050 ↗
72. A clinical significance of fungal infections in diabetic foot ulcers
73. A study on prevalence, profile, and risk factors of developing fungal infection in patients with diabetic foot ulcer10.25270/wmp.22076 ↗
74. Gupta, A.K., Shemer, A., Economopoulos, V., and Talukder, M. (2024). Diabetic foot and fungal infections: Etiology and management from a dermatologic perspective. J. Fungi, 10.10.3390/jof10080577 ↗
75. Ge, Y., and Wang, Q. (2023). Current research on fungi in chronic wounds. Front. Mol. Biosci., 9.10.3389/fmolb.2022.1057766 ↗
76. ClinicalTrials.gov (2026, March 17). Fungal Infection in Patients with Diabetic Foot Osteomyelitis. ClinicalTrials.gov Identifier: NCT04041739, Available online: https://clinicaltrials.gov/study/NCT04041739.
77. Boulton, A.J.M., Armstrong, D.G., Hardman, M.J., Malone, M., Embil, J.M., Attinger, C.E., Lipsky, B.A., Aragón-Sánchez, J., Li, H.K., and Schultz, G. (2026, March 17). Diagnosis and Management of Diabetic Foot Infections, Available online: https://www.ncbi.nlm.nih.gov/books/NBK554227/.
78. Clinical microbiological study of fungal infections in diabetic foot ulcers: The hidden hindrance
79. Priority effects dictate community structure and alter virulence of fungal–bacterial biofilms10.1038/s41396-021-00901-5 ↗
80. Fungi in the wound microbiome10.1089/wound.2017.0756 ↗
81. Recent advances in artificial intelligent strategies for tissue engineering and regenerative medicine10.1111/srt.70016 ↗
82. A digital light processing 3D-printed artificial skin model and full-thickness wound models using silk fibroin bioink10.1016/j.actbio.2023.04.034 ↗
83. Next-generation 3D-printed bioengineered skin grafts: From experimental validation to clinical implementation10.30574/wjbphs.2025.23.1.0694 ↗
84. (2026, March 17). D-Printed Living Skin: The Future of Skin Grafts?. Available online: https://www.medicaldevice-network.com/features/3d-printed-skin/?cf-view.
85. Columbia University Irving Medical Center (2026, March 17). Bioengineered Skin Grafts That Fit Like a Glove 2023. Available online: https://www.cuimc.columbia.edu/news/bioengineered-skin-grafts-fit-glove.
86. Yeh, C.C., Lin, Y.S., Chen, C.C., and Liu, C.F. (2023). Implementing AI models for prognostic predictions in high-risk burn patients. Diagnostics, 13.10.3390/diagnostics13182984 ↗
87. Artificial intelligence recognition of cutaneous chronic graft-versus-host disease by a deep learning neural network10.1111/bjh.18141 ↗
88. Kang, M.S., Jang, J., Jo, H.J., Kim, W.H., Kim, B., Chun, H.J., Lim, D., and Han, D.W. (2022). Advances and innovations of 3D bioprinting skin. Biomolecules, 13.10.3390/biom13010055 ↗
89. Application of artificial intelligence in tissue engineering10.1089/ten.teb.2024.0022 ↗
90. Nosrati, H., and Nosrati, M. (2023). Artificial intelligence in regenerative medicine: Applications and implications. Biomimetics, 8.10.3390/biomimetics8050442 ↗
91. Harnessing the power of machine learning into tissue engineering: Current progress and future prospects10.1093/burnst/tkae053 ↗
92. Research progress in artificial intelligence-assisted preparation of high-quality biomaterials
93. Antezana, P.E., Municoy, S., Álvarez-Echazú, M.I., Santo-Orihuela, P.L., Catalano, P.N., Al-Tel, T.H., Kadumudi, F.B., Dolatshahi-Pirouz, A., Orive, G., and Desimone, M.F. (2022). The 3D bioprinted scaffolds for wound healing. Pharmaceutics, 14.10.3390/pharmaceutics14020464 ↗
94. 3D bioprinting for skin tissue engineering: Current status and perspectives10.1177/20417314211028574 ↗
95. Misir, A. (2025). Artificial intelligence and machine learning in diabetic foot ulcer care: Advances in diagnosis, treatment, prognosis, and novel therapeutic strategies. J. Diabetes Sci. Technol., 19322968251363632.10.1177/19322968251363632 ↗
96. Alkhalefah, S., AlTuraiki, I., and Altwaijry, N. (2025). Advancing diabetic foot ulcer care: Ai and generative ai approaches for classification, prediction, segmentation, and detection. Healthcare, 13.10.37766/inplasy2025.2.0066 ↗
97. Three-dimensional printing in developing countries10.1097/GOX.0000000000000298 ↗
98. AMFG (2026, March 17). How Can 3D Printing Benefit Underdeveloped Countries?. Available online: https://www.amfg.ai/post/how-can-3d-printing-benefit-underdeveloped-countries.
99. Ontario Hospital Association (2026, March 17). AI Wound Care Will Shape the Delivery of Care in Rural Communities. Available online: https://www.oha.com/news/ai-wound-care-will-shape-the-delivery-of-care-in-rural-communities.
100. American Society of Plastic Surgeons (2026, March 17). 3D Printing May Help Improve Health Care in Developing Countries. Available online: https://www.plasticsurgery.org/news/press-releases/3d-printing-may-help-improve-health-care-in-developing-countries.